BWX Technologies said this week it had reached a significant milestone in preparing for production and commercialization of the medical isotope molybdenum-99 (Mo-99), while acknowledging that its overall program has fallen behind schedule.
Based in Lynchburg, Va.,…
SUBSCRIBER ACCESS
Thank you for visiting
RadWaste Monitor!
You must be logged in as a subscriber to view this page.
